This podcast focuses on how emerging tools can enable better collaboration and engagement with both internal and external stakeholders.
The webinar addresses the importance of metrics and how Share of Scientific Voice provides measurement in one of MA's most strategically important areas: external stakeholder engagement and scientific impact.
This podcast focuses on how to use integrated HCP data and network analytics to get faster, better insights from disease communities.
ZS is a management consulting and technology firm focused on transforming global healthcare and beyond.
A diverse discussion between an MSL, a Medical Field Excellence Leader, and a Solution Provider on an aligned partnership to supercharge scientific exchange.
• Discuss the power of the empowered MSL by sharing fresh and modern view-points
• Identify new field excellence standards to enable stronger collaboration within Medical Affairs to supercharge scientific exchange
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the future of the Medical Affairs function and the factors driving the current pace of change.
The webinar is intended to build upon recent publications and ongoing discussions on the use of KPIs & metrics in Medical Affairs. The speakers will discuss real world and novel approaches that may be customized in order to create MA metrics that are relevant, and most meaningful to showcase the value of Med Affairs in a rapidly changing healthcare ecosystem.
Thus, the audience will learn how metrics specific to various MA roles/ functions may be measured, monitored more continuously, and communicated with the right internal and external stakeholders at the right time.
After attending the webinar, the audience will receive a bonus downloadable Medical Affairs Metrics Workbook with a detailed summary of the MPI (Medical Productivity Index) case study including a template to monitor qualitative outcomes, an Ideal Metrics “checklist” and scoring system, as well as detailed survey question examples of both internal and external next generation metrics to simplify and shorten the end of year performance review process in addition to the copy of the webinar slide deck.
1. Provide an overview of the most relevant metrics to better communicate the value of Medical Affairs
2. Describe COVID-related changes in Medical Affairs and their impact on metrics
3. Learn new approaches to monitoring metrics more continuously and consistently over time
Pharmaceutical teams need a different way to approach working virtually. The secret isn’t adding more virtual calls, but unlocking the strategic power of virtual work. Download this white paper to see how your peers are achieving more, with fewer meetings.
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.
Evidence is emerging to demonstrate the value of patient engagement throughout the medicine development lifecycle. Consequently, many pharmaceutical companies are adopting more patient‑centric approaches and a range of tools are available to support this. There are many case studies highlighting effective patient involvement in clinical trial design, or in the development of patient education materials – but we rarely see patient involvement in company-sponsored medical publications.
Patients have valuable and unique insights into key areas such as the lived experience, treatment journeys, and unmet needs. Their perspectives should be captured to strengthen the peer-reviewed medical literature. In this session we will highlight the opportunities for patients to become authors and review some of the tools and training available to support them. Using a recent case study, we will show how patients can and do add value as co-authors of company-sponsored publications.